Syntrix Presents at the 2012 Life Science Invest Northwest Conference in Seattle
Syntrix President John A Zebala, MD, PhD presented at the 2012 Life Science Invest Northwest (LSINW) Conference in Seattle. The Syntrix presentation featured Omnitram, the company’s new oral treatment for acute, chronic and neuropathic pain. LSINW brings together nearly 1,000 attendees from public and private companies, research institutions and the global health communit.
Read about Omnitram in our pipeline.